Links to 7 New Hepatitis C Articles

[Guest guest]

Programs May Curb Hepatitis C in Drug Users

Fox News

Programs that give injection drug users clean needles or safer drug substitutes

may help cut their odds of contracting the liver infection hepatitis C, a new

study suggests. The hepatitis C virus is passed through contact with infected

blood. ...

See all stories on this topic »Vertex Hepatitis Drug Takes Early Lead Over Rival

From Merck

Wall Street Journal

By Loftus Of DOW JONES NEWSWIRES Vertex Pharmaceuticals Inc.'s (VRTX) new

hepatitis C drug Incivek has taken an early lead over rival drug Victrelis from

Merck & Co. (MRK) in what is expected to become a multibillion-dollar market.

....

See all stories on this topic »PAKISTAN: Health personnel spread hepatitis

IRINnews.org

LAHORE, 29 June 2011 (IRIN) - A year after Muhammad Ahsan's elder brother,

Muhammad Rafiq, 40, died of hepatitis C, the family has learnt that the widow,

Amna Bibi, 35, has also contracted the infection. “We spent over Rs 150000

[uS$1764] on my ...

See all stories on this topic »New drug shows breakthrough in treatment of

hepatitis C

Jerusalem Post

COM STAFF Drug Telaprevir, " the first in a coming wave of new treatments, "

represents first hepatitis C drug that has demonstrated success in patients who

have failed prior therapy. NEW YORK - The drug telaprevir (Incivek) provides a

dramatic ...

See all stories on this topic »Extended therapy for hepatitis C

Clinical Advisor

A patient who is being treated for hepatitis C genotype 1a did not achieve an

early viral response to interferon and ribavirin therapy at four weeks. However,

a steady slow drop with resulting nondetectable viral load did occur at week 20

of a 48-week ...

See all stories on this topic »New Hep C drug reduces treatment time

CBC.ca

Performer Pamela announced she has hepatitis C in 2002. A new drug is

helping to reduce treatment time, researchers have found. JP Moczulski/Canadian

Press Adding a new hepatitis C drug to standard medications improves the

effectiveness of ...

See all stories on this topic » Research and Markets: A Hepatitis C Global

Clinical Trials Review for Q2, 2011 ...

Business Wire (press release)

GlobalData's clinical trial report, Hepatitis C Global Clinical Trials Review,

Q2, 2011 provides data on the Hepatitis C clinical trial scenario. This report

provides elemental information and data relating to the clinical trials on

Hepatitis C. It ...

See all stories on this topic »

[Guest guest]

Programs May Curb Hepatitis C in Drug Users

Fox News

Programs that give injection drug users clean needles or safer drug substitutes

may help cut their odds of contracting the liver infection hepatitis C, a new

study suggests. The hepatitis C virus is passed through contact with infected

blood. ...

See all stories on this topic »Vertex Hepatitis Drug Takes Early Lead Over Rival

From Merck

Wall Street Journal

By Loftus Of DOW JONES NEWSWIRES Vertex Pharmaceuticals Inc.'s (VRTX) new

hepatitis C drug Incivek has taken an early lead over rival drug Victrelis from

Merck & Co. (MRK) in what is expected to become a multibillion-dollar market.

....

See all stories on this topic »PAKISTAN: Health personnel spread hepatitis

IRINnews.org

LAHORE, 29 June 2011 (IRIN) - A year after Muhammad Ahsan's elder brother,

Muhammad Rafiq, 40, died of hepatitis C, the family has learnt that the widow,

Amna Bibi, 35, has also contracted the infection. “We spent over Rs 150000

[uS$1764] on my ...

See all stories on this topic »New drug shows breakthrough in treatment of

hepatitis C

Jerusalem Post

COM STAFF Drug Telaprevir, " the first in a coming wave of new treatments, "

represents first hepatitis C drug that has demonstrated success in patients who

have failed prior therapy. NEW YORK - The drug telaprevir (Incivek) provides a

dramatic ...

See all stories on this topic »Extended therapy for hepatitis C

Clinical Advisor

A patient who is being treated for hepatitis C genotype 1a did not achieve an

early viral response to interferon and ribavirin therapy at four weeks. However,

a steady slow drop with resulting nondetectable viral load did occur at week 20

of a 48-week ...

See all stories on this topic »New Hep C drug reduces treatment time

CBC.ca

Performer Pamela announced she has hepatitis C in 2002. A new drug is

helping to reduce treatment time, researchers have found. JP Moczulski/Canadian

Press Adding a new hepatitis C drug to standard medications improves the

effectiveness of ...

See all stories on this topic » Research and Markets: A Hepatitis C Global

Clinical Trials Review for Q2, 2011 ...

Business Wire (press release)

GlobalData's clinical trial report, Hepatitis C Global Clinical Trials Review,

Q2, 2011 provides data on the Hepatitis C clinical trial scenario. This report

provides elemental information and data relating to the clinical trials on

Hepatitis C. It ...

See all stories on this topic »